Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Exciting New Potential Treatment for Malaria

Super Critical Extraction New Zealand & Australia Pty Limited

Press Release Australian and NZ Press Associations and others:

Exciting New Potential Treatment for Malaria

Super Critical Extraction New Zealand & Australia Pty Limited (“SCENZA”) today announced the development of two new and distinct nutraceutical treatment delivery systems in the fight against Malaria. Each formulation contains active ingredient artemisinin.
These delivery systems are to be trialed immediately in Papua New Guinea.

One treatment system is delivered in tablet form aimed at the adult market, the other in lozenge form with a lower dose of artemisinin, aimed at treating children. The active ingredient, artemisinin is an important component found in the Chinese herb, Artemisia Annua. SCENZA has a supply of high quality, super critically extracted artemisinin extracted at the company’s plant at Beechworth in Victoria.

Artemisinin is recognized as the pre-eminent natural substance contained in ACT’s or Artemisinin –based Combination Therapies being developed in the world-wide fight against malaria. These new formulations use several compounds in conjunction with the active ingredient, artemisinin to help reduce the odds of a mutation effect on the ability of artemisinin to fight the malaria parasite.

A nutraceutical formulation, which means the main ingredient comes from a natural plant extract, allows this to be a low cost remedy for alleviating the symptoms of this energy sapping tropical disease.

Many of the countries affected by Malaria cannot afford high cost pharmaceutical drugs in the fight against these tropical and debilitating diseases hence the nutraceutical formulation.

The company reports that it is working closely with doctors and naturopaths in Papua New Guinea to conduct a trial for its two new formulations. The company has finalized the specification, methodology and protocols of the a trials.

In anticipation of a successful trial, discussions are already well advanced with potential distributors for handling the introduction of these two new low cost remedies in Papua New Guinea.


© Scoop Media

Business Headlines | Sci-Tech Headlines


By May 2018: Wider, Earlier Microbead Ban

The sale and manufacture of wash-off products containing plastic microbeads will be banned in New Zealand earlier than previously expected, Associate Environment Minister Scott Simpson announced today. More>>


Snail-ier Mail: NZ Post To Ditch FastPost

New Zealand Post customers will see a change to how they can send priority mail from 1 January 2018. The FastPost service will no longer be available from this date. More>>


Property Institute: English Backs Of Debt To Income Plan

Property Institute of New Zealand Chief Executive Ashley Church is applauding today’s decision, by Prime Minister Bill English, to take Debt-to-income ratios off the table as a tool available to the Reserve Bank. More>>


Divesting: NZ Super Fund Shifts Passive Equities To Low-Carbon

The NZ$35 billion NZ Super Fund’s NZ$14 billion global passive equity portfolio, 40% of the overall Fund, is now low-carbon, the Guardians of New Zealand Superannuation announced today. More>>


Split Decision - Appeal Planned: EPA Allows Taranaki Bight Seabed Mine

The Decision-making Committee, appointed by the Board of the Environmental Protection Authority to decide a marine consent application by Trans-Tasman Resources Ltd, has granted consent, subject to conditions, for the company to mine iron sands off the South Taranaki Bight. More>>